Bilirubin-Induced Neurotoxicity and Environmental Impacts on Hyperbilirubinemia DevelopmentYueh, Mei Fei; Chen, Shujuan; Nguyen, Nghia; Tukey, Robert H · Journal of Environmental & Analytical Toxicology · 2016

Crypt organoids culture as an <i>in vitro</i> model in drug metabolism and cytotoxicity studiesLu, Wenqi; Rettenmeier, Eva; Paszek, Miles; Yueh, Mei-Fei; Tukey, Robert H.; Trottier, Jocelyn; Barbier, Olivier; Chen, Shujuan · Drug Metabolism and Disposition · 2017

Stage-specific regulation of the WNT/β-catenin pathway results in improved differentiation of hESCs to functional hepatocytesTouboul, Thomas; Chen, Shujuan; To, Cuong C.; Mora-Castilla, Sergio; Sabatini, Karen; Tukey, Robert H.; Laurent, Louise C. · Journal of Hepatology · 2016

Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARαHinds, Terry D.; Hosick, Peter A.; Chen, Shujuan; Tukey, Robert H.; Hankins, Michael W.; Nestor-Kalinoski, Andrea; Stec, David E. · American Journal of Physiology - Endocrinology And Metabolism · 2017

Unusual GlucuronidesArgikar, U. A. · Drug Metabolism and Disposition · 2012

ACETAMINOPHEN-INDUCED HEPATOTOXICITYJames, L. P. · Drug Metabolism and Disposition · 2003

HEPATOBILIARY EXCRETION OF BERBERINETsai, P.-L. · Drug Metabolism and Disposition · 2004

CANCER CHEMOTHERAPY AND DRUG METABOLISMRiddick, D. S. · Drug Metabolism and Disposition · 2005

Which Metabolites Circulate?Loi, C.-M.; Smith, D. A.; Dalvie, D. · Drug Metabolism and Disposition · 2013

CHOLESTEROL-METABOLIZING CYTOCHROMES P450Pikuleva, I. A. · Drug Metabolism and Disposition · 2006

AnnouncementBarrett, J. E. · Drug Metabolism and Disposition · 2011

Possible Bioactivation Pathways of LamotrigineLu, W.; Uetrecht, J. P. · Drug Metabolism and Disposition · 2007